Answer in brief
CVE-2026-123218 records a Critical severity (CVSS 9.8) vulnerability in IBM Aspera Faspex Authorization Bypass. The current sources do not mark it as known exploited. The current feed maps IBM/Aspera Faspex (generic). Check affected ranges and fixed versions before updating.
Analysis pending evidence review
HOL Guard separates source facts from reviewed analysis. See the methodology.
CVSS is 9.8. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.
Analysis status
Analysis pending evidence review
Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.
The current feed maps IBM/Aspera Faspex (generic). Check affected ranges and fixed versions before updating.
| Package | Affected range | Fixed version |
|---|---|---|
| IBM/Aspera Faspexgeneric | >=5.0.0 <=5.0.19 | Not reported |
Published upstream
Nov 7, 2026
Evidence: source:cvelist:source_dates:source-dates:recordSource modified
Nov 7, 2026
Evidence: source:cvelist:source_dates:source-dates:recordFirst seen by HOL
Nov 7, 2026
IBM Aspera Faspex 5.0.0 through 5.0.19 could allow an authorized user to craft a specific message to bypass user authorization and gain full administrative privileges.
Quoted source text, attributed separately from HOL analysis.